• 1. Diazaindenes (azaindoles). Part III. Reactions of Vilsmeier reagents leading to 3-formyl-1,6-diazaindene and -1,4-diazabenz[f]indene
  B. A. J. Clark,J. Parrick,P. J. West,A. H. Kelly J. Chem. Soc. C 1970 498
• 2. The conversion of [(4-chloro-5H-1,2,3-dithiazol-5-ylidene)amino]azines into azine fused thiazole-2-carbonitriles
  Panayiotis A. Koutentis,Maria Koyioni,Sophia S. Michaelidou Org. Biomol. Chem. 2013 11 621
• 3. The electric dipole moments of toluidines and some aminopicolines in benzene and 1,4-dioxan solution
  C. W. N. Cumper,A. Singleton J. Chem. Soc. B 1967 1100
• 4. Copper-mediated three-component synthesis of 2-trifluoromethyl benzimidazoles
  Chenhui You,Yangjie Huang,Yi You,Zhiqiang Weng Org. Chem. Front. 2022 9 3247
• 5. Recent developments in the synthesis of azaindoles from pyridine and pyrrole building blocks
  Damoder Reddy Motati,Radhika Amaradhi,Thota Ganesh Org. Chem. Front. 2021 8 466

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Introduction to 4-methylpyridin-3-amine (CAS No. 3430-27-1)

4-methylpyridin-3-amine, with the chemical formula C?H?N?, is a significant compound in the field of pharmaceutical and chemical research. Its CAS number, 3430-27-1, uniquely identifies it in scientific literature and industrial applications. This heterocyclic amine derivative is characterized by a pyridine ring substituted with a methyl group at the 4-position and an amine group at the 3-position. The structural features of 4-methylpyridin-3-amine make it a versatile intermediate in the synthesis of various biologically active molecules.

The compound's unique electronic properties, arising from the presence of nitrogen atoms in its structure, contribute to its reactivity and utility in organic synthesis. Researchers have leveraged these properties to develop novel methodologies for constructing complex molecular architectures. For instance, the amine functionality allows for facile nucleophilic substitution reactions, making 4-methylpyridin-3-amine a valuable building block in the preparation of pharmacophores targeting neurological and cardiovascular diseases.

Recent advancements in medicinal chemistry have highlighted the importance of 4-methylpyridin-3-amine in drug discovery. Its structural motif is found in several FDA-approved drugs, where it serves as a key pharmacophore contributing to therapeutic efficacy. A notable example is its role in the development of small-molecule inhibitors targeting enzymes involved in cancer metabolism. These inhibitors have shown promise in preclinical studies by selectively modulating key metabolic pathways, thereby inhibiting tumor growth and proliferation.

The synthesis of 4-methylpyridin-3-amine can be achieved through multiple routes, each with distinct advantages depending on scalability and purity requirements. One common method involves the reduction of 3-methylpyridine-nitrile using catalytic hydrogenation techniques. Alternatively, nucleophilic aromatic substitution reactions on 4-methylpyridine halides can yield the desired product with high regioselectivity. These synthetic strategies have been optimized to ensure cost-effective production while maintaining high yields and minimal byproduct formation.

In industrial applications, 4-methylpyridin-3-amine is utilized as a precursor in the manufacture of agrochemicals and specialty chemicals. Its derivatives exhibit herbicidal and fungicidal properties, contributing to sustainable agricultural practices. Furthermore, its incorporation into liquid crystals and organic semiconductors underscores its significance beyond pharmaceuticals, demonstrating its versatility across multiple scientific disciplines.

The pharmacological profile of 4-methylpyridin-3-amine has been extensively studied due to its potential therapeutic applications. Research indicates that derivatives of this compound can modulate neurotransmitter release, making them candidates for treating neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Additionally, its ability to interact with metal ions has led to investigations into its role as a chelating agent for metal-based therapeutics.

Regulatory considerations are critical when handling 4-methylpyridin-3-amine, ensuring compliance with safety protocols in laboratory and industrial settings. While not classified as a hazardous material under current regulations, proper handling procedures must be followed to mitigate any potential health risks associated with exposure. Storage conditions should be controlled to prevent degradation, particularly when exposed to light or moisture.

The future prospects for 4-methylpyridin-3-amine are promising, with ongoing research exploring novel synthetic pathways and expanding its applications in drug discovery. Collaborative efforts between academia and industry are driving innovation, aiming to harness its full potential in addressing unmet medical needs. As synthetic methodologies continue to evolve, the accessibility and efficiency of producing this compound will further enhance its utility across diverse scientific domains.

In conclusion,4-methylpyridin-3-amine (CAS No. 3430-27-1) remains a cornerstone in chemical synthesis and pharmaceutical research due to its structural versatility and biological relevance. Its continued study promises to yield groundbreaking advancements in medicine and material science, reinforcing its importance as a fundamental building block in modern chemistry.

• 78790-79-1(3-Amino-4-cyanopyridine)
• 144288-49-3(4-(Aminomethyl)pyridin-3-amine)
• 165387-82-6(4-Phenyl-Pyridin-3-Ylamine Dihydrochloride)
• 55279-29-3(3-aminopyridine-4-carbaldehyde)
• 516513-80-7(4-Benzylpyridin-3-amine)
• 152398-05-5((3-aminopyridin-4-yl)methanol)
• 146140-99-0(4-Phenylpyridin-3-amine)
• 101084-17-7(4-Ethylpyridin-3-amine)
• 52311-43-0(BTPY-NH2)
• 105973-92-0(4-Phenethylpyridin-3-amine)